Related Experiment Video

Updated: Jun 25, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Improving the evaluation of new cancer treatments: challenges and opportunities

Mace L Rothenberg1, David P Carbone, David H Johnson

  • 1Vanderbilt-Ingram Cancer Center, 777 Preston Research Building, Nashville, Tennessee 37232-6307, USA. mace.rothenberg@vanderbilt.edu

Nature Reviews. Cancer
|April 3, 2003
PubMed

Insights

The number of anticancer drugs in clinical trials has surged. New targeted therapies require redesigned clinical trials to effectively evaluate their efficacy in specific patient groups.

Area of Science:

  • Oncology
  • Clinical Pharmacology
  • Drug Development

Background:

  • Significant increase in the number of anticancer drugs undergoing clinical trials.
  • Emergence of novel targeted anticancer agents with specific mechanisms of action.
  • Challenges posed by the heterogeneity of patient responses to new therapies.

Purpose of the Study:

  • To address the need for redesigned clinical trials for targeted anticancer drugs.
  • To explore innovative trial designs accommodating novel therapeutic strategies.
  • To optimize the evaluation of anticancer agents in specific patient subpopulations.

Main Methods:

  • Review of current clinical trial methodologies.
  • Analysis of the characteristics of novel targeted anticancer drugs.
  • Exploration of adaptive and biomarker-driven trial designs.

Main Results:

  • Current trial designs may not be optimal for targeted therapies.
  • Small patient subpopulations necessitate focused trial recruitment.
  • Unpredictable drug interactions require careful trial planning.

Conclusions:

  • Clinical trials must evolve to incorporate targeted drug development.
  • Biomarker-based stratification and adaptive designs are crucial.
  • Redesigned trials are essential for efficient evaluation of novel anticancer agents.

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...